MedX Health Corp develops and markets skin-related screening tools and phototherapy devices for pain relief and tissue repair. The company faces significant financial challenges, reflected in a low gross margin of 19.9% and alarming negative margins, indicating operational inefficiencies. Additionally, a current ratio of 0.11 and quick ratio of 0.07 suggest liquidity issues. While the market cap is relatively low at $14.76M, the lack of profitability raises concerns about sustainability and growth potential. Overall, the company needs to address its financial health to improve investor confidence.
Loading financial metrics...
Company has $127K in cash but burned $469K last quarter. At this burn rate, only 0.3 quarters of runway remain without additional financing.
Company posted a loss of $-2.9M over the last year, representing 1459.3% of revenue.
Debt of $7.3M is 57.6x the company's cash position of $127K.
No significant opportunities identified
Based on current financial metrics
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Medical Devices companies of a similar size
Based on 2025-Q2 (June 30, 2025)